Intravitreal Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy in Pediatric Patients
Data from this small and variable sample size demonstrates the potential of intravitreal methotrexate injections to be an effective agent for the treatment and prevention of PVR in the pediatric population.
Authors
- Philip J. Ferrone (ORCID: https://orcid.org/0000-0003-1748-4614)
- Daniel Zhu (ORCID: https://orcid.org/0000-0001-6569-9623)
- David W. Rhee (ORCID: https://orcid.org/0000-0002-7192-6025)
- Juan Manuel Márquez-Romero (ORCID: https://orcid.org/0000-0002-5059-1174)
- Michael Bouaziz (ORCID: https://orcid.org/0000-0001-6611-4973)
- George Jiao
- Jessica G. Lee
Institutions
- Vitreous Retina Macula Consultants of New York (US)
- Northwell Health Orthopaedic Institute (US)
Publication Details
- Journal
- Ophthalmic surgery, lasers & imaging retina
- Published
- 2025-10-20
- DOI
- https://doi.org/10.3928/23258160-20250818-03
- Primary Topic
- Retinal and Macular Surgery
- Type
- article
- Field-Weighted Citation Impact
- 0.00